Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive

被引:3
作者
Guerra, Peter G. [1 ,14 ]
Simpson, Christopher S. [2 ]
Van Spall, Harriette G. C. [3 ]
Asgar, Anita W. [1 ]
Billia, Phyllis [4 ]
Cadrin-Tourigny, Julia [1 ]
Chakrabarti, Santabhanu [5 ,6 ]
Cheung, Christopher C. [7 ]
Dore, Annie [1 ]
Fordyce, Christopher B. [5 ,6 ]
Gouda, Pishoy [8 ]
Hassan, Ansar [9 ]
Krahn, Andrew [5 ,6 ]
Luc, Jessica G. Y. [5 ,6 ]
Mak, Susanna [10 ]
McMurtry, Sean [8 ]
Norris, Colleen [8 ]
Philippon, Francois [11 ]
Sapp, John [12 ]
Sheldon, Robert [13 ]
Silversides, Candice [4 ]
Steinberg, Christian [11 ]
Wood, David A. [5 ,6 ]
机构
[1] Inst Cardiol Montreal, Univ Montreal, Montreal, PQ, Canada
[2] Queens Univ, Kingston Hlth Sci Ctr, Kingston, ON, Canada
[3] Baim Inst Clin Res, Boston, MA USA
[4] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[5] Univ British Columbia, Div Cardiol, Vancouver, BC, Canada
[6] Univ British Columbia, Ctr Cardiovasc Innovat, Vancouver, BC, Canada
[7] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[8] Univ Alberta, Edmonton, AB, Canada
[9] Mitral Ctr Excellence, Maine Med Ctr, Portland, ME USA
[10] Univ Toronto, Sinai Hlth, Toronto, ON, Canada
[11] Hop Laval, Inst Univ Cardiol & Pneumol Quebec, Laval, PQ, Canada
[12] Dalhousie Univ, QEII Hlth Sci Ctr, Halifax, NS, Canada
[13] Univ Calgary, Calgary, AB, Canada
[14] Univ Montreal, Montreal Heart Inst, 5000 Belanger St, Montreal, PQ H1T 1C8, Canada
关键词
SUDDEN CARDIAC DEATH; PERCUTANEOUS CORONARY INTERVENTION; AORTIC-VALVE-REPLACEMENT; QUALITY-OF-LIFE; HEART-FAILURE; CARDIOVERTER-DEFIBRILLATOR; VENTRICULAR-ARRHYTHMIAS; EUROPEAN-SOCIETY; MYOCARDIAL-INFARCTION; RISK STRATIFICATION;
D O I
10.1016/j.cjca.2023.09.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular conditions are among the most frequent causes of impairment to drive, because they might induce unpredictable mental state alterations via diverse mechanisms like myocardial ischemia, cardiac arrhythmias, and vascular dysfunction. Accordingly, health professionals are often asked to assess patients ' fi tness to drive (FTD). The Canadian Cardiovascular Society previously published FTD guidelines in 2003-2004; herein, we present updated FTD guidelines. Because there are no randomized trials on FTD, observational studies were used to estimate the risk of driving impairment in each situation, and recommendations made on the basis of Canadian Cardiovascular Society Risk of Harm formula. More restrictive recommendations were made for commercial drivers, who spend longer average times behind the wheel, use larger vehicles, and might transport a larger number of passengers. We provide guidance for individuals with: (1) active coronary artery disease; (2) various forms of valvular heart disease; (3) heart failure, heart transplant, and left ventricular assist device situations; (4) arrhythmia syndromes; (5) implantable devices; (6) syncope history; and (7) congenital heart disease. We suggest appropriate waiting times after cardiac interventions or acute illnesses before driving resumption. When short-term driving cessation is recommended, recommendations are on the basis of expert consensus rather than the Risk of Harm formula because risk elevation is expected to be transient. These recommendations, although not a substitute for clinical judgement or governmental regulations, provide specialists, primary care providers, and allied health professionals with a comprehensive list of a wide range of cardiac conditions, with guidance provided on the basis of the level of risk of impairment, along with recommendations about ability to drive and the suggested duration of restrictions.
引用
收藏
页码:500 / 523
页数:24
相关论文
共 123 条
  • [1] Sudden Death After Myocardial Infarction
    Adabag, A. Selcuk
    Therneau, Terry M.
    Gersh, Bernard J.
    Weston, Susan A.
    Roger, Veronique L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (17): : 2022 - 2029
  • [2] An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome
    Adler, Arnon
    Novelli, Valeria
    Amin, Ahmad S.
    Abiusi, Emanuela
    Care, Melanie
    Nannenberg, Eline A.
    Feilotter, Harriet
    Amenta, Simona
    Mazza, Daniela
    Bikker, Hennie
    Sturm, Amy C.
    Garcia, John
    Ackerman, Michael J.
    Hershberger, Raymond E.
    Perez, Marco V.
    Zareba, Wojciech
    Ware, James S.
    Wilde, Arthur A. M.
    Gollob, Michael H.
    [J]. CIRCULATION, 2020, 141 (06) : 418 - 428
  • [3] Al-Khatib SM, 2018, CIRCULATION, V138, pE272, DOI [10.1161/CIR.0000000000000549, 10.1161/CIR.0000000000000548]
  • [4] Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation
    Allen, Jeremiah G.
    Weiss, Eric S.
    Schaffer, Justin M.
    Patel, Nishant D.
    Ullrich, Susan L.
    Russell, Stuart D.
    Shah, Ashish S.
    Conte, John V.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (03) : 278 - 285
  • [5] Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up
    Alnasser, Sami M. A.
    Huang, Wei
    Gore, Joel M.
    Steg, Gabriel
    Eagle, Kim A.
    Anderson, Frederick A., Jr.
    Fox, Keith A. A.
    Gurfinkel, Enrique
    Brieger, David
    Klein, Werner
    van de Werf, Frans
    Avezum, Alvaro
    Montalescot, Gilles
    Gulba, Dietrich C.
    Budaj, Andrzej
    Lopez-Sendon, Jose
    Granger, Christopher B.
    Kennelly, Brian M.
    Goldberg, Robert J.
    Fleming, Emily
    Goodman, Shaun G.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2015, 128 (07) : 766 - 775
  • [6] [Anonymous], 1992, CAN J CARDIOL, V8, P406
  • [7] [Anonymous], 1996, CAN J CARDIOL, V12, P1164
  • [8] Canadian Cardiovascular Society Focused Position Statement Update on Assessment of the Cardiac Patient for Fitness to Drive: Fitness Following Left Ventricular Assist Device Implantation
    Baskett, Roger
    Crowell, Richard
    Freed, Darren
    Giannetti, Nadia
    Simpson, Christopher S.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (02) : 137 - 140
  • [9] Optimal medical therapy with or without PCI for stable coronary disease
    Boden, William E.
    O'Rourke, Robert A.
    Teo, Koon K.
    Hartigan, Pamela M.
    Maron, David J.
    Kostuk, William J.
    Knudtson, Merril
    Dada, Marcin
    Casperson, Paul
    Harris, Crystal L.
    Chaitman, Bernard R.
    Shaw, Leslee
    Gosselin, Gilbert
    Nawaz, Shah
    Title, Lawrence M.
    Gau, Gerald
    Blaustein, Alvin S.
    Booth, David C.
    Bates, Eric R.
    Spertus, John A.
    Berman, Daniel S.
    Mancini, G. B. John
    Weintraub, William S.
    Boden, W.
    O'Rourke, R.
    Teo, K.
    Hartigan, P.
    Weintraub, W.
    Maron, D.
    Mancini, J.
    Weintraub, W.
    Boden, W.
    O'Rourke, R.
    Teo, K.
    Hartigan, P.
    Knudtson, M.
    Maron, D.
    Bates, E.
    Blaustein, A.
    Booth, D.
    Carere, R.
    Ellis, S.
    Gosselin, G.
    Gau, G.
    Jacobs, A.
    King, S., III
    Kostuk, W.
    Harris, C.
    Spertus, J.
    Peduzzi, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) : 1503 - 1516
  • [10] Pathophysiology, clinical course, and management of congenital complete atrioventricular block
    Bordachar, Pierre
    Whinnett, Zachary
    Ploux, Sylvain
    Labrousse, Louis
    Haissaguerre, Michel
    Thambo, Jean-Benoit
    [J]. HEART RHYTHM, 2013, 10 (05) : 760 - 766